28 Jun, 2016Federated identity knocks down silos for clinical drug research
Clinical drug research has been highly compartmentalized but Transcelerate is looking to knock down those silos and make identity easy. The Shared Investigator Platform is using credentials from Exostar that comply with the SAFE-BioPharma digital identity standards.